Nasal spray vaccine aims to shield children from RSV
Vaccine
Stopped early
This early-stage trial tests an experimental RSV vaccine called CodaVax-RSV, given as nose drops, in healthy children aged 6 months to 5 years. The study evaluates the vaccine's safety and the immune response it triggers. Some children receive the vaccine at different doses, whil…
Phase 1 • Sponsor: Codagenix, Inc • Aim: Vaccine
Last updated Jul 17, 2026 00:00 UTC